Type 2 & other diabetes

Effectiveness and cost‐effectiveness of an app and rewards‐based intervention in type 2 diabetes: A randomised controlled trial

Diabetes Obes MetabPublished Randomised controlled trial

Authors' conclusion

A comprehensive app-based diabetes self-management programme with rewards for healthy behaviours and health outcomes (DMP+) cost-effectively improved glycaemic control in Type 2 diabetes patients. Organizations focusing on value-based healthcare should consider subsidising similar interventions.

Study context

Population
Adults with T2D, HbA1c 7.5%-11.0% (inclusive), taking at least one oral diabetes medication; Duke-NUS Medical School, Singaporerandomised
Participants
269 adults
Comparison
App-based diabetes self-management programme with rewards vs usual care
  • Usual care (UC)n = 117reference
  • Diabetes management programme (DMP)n = 36
  • DMP+n = 116
Primary endpoint
Change in HbA1c between DMP+ and UC
Follow-up
Month 12
Methodological detailsopen-label, parallel-group, three arms
  • Open-label
  • Parallel-group
  • Three arms

Primary result

Mean HbA1c improvement · 12 months

Mean difference

0.4 %

95% CI −0.70 to −0.08

P = 0.015

Change by group

UC

0.1

mean · %

DMP+

0.5

mean · %

As reported in the abstract

Further findings

OutcomeOR (95% CI)P value
HbA1c improvement >0.5% · 12 monthsDMP+vs UC2.12 (1.17–3.85)P = 0.013

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effectiveness and cost‐effectiveness of an app and rewards‐based intervention in type 2 diabetes: A randomised controlled trial. Diabetes Obes Metab. Published 5 December 2024. doi:10.1111/dom.16067

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.